Envista Holdings Corp
HealthcareNYSE:NVST · New York Stock Exchange
+$0.10 today
Vol 2.17M · Avg 2.97M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+33.33%
Period High
$30.26
Period Low
$18.43
Latest
$24.60
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.47B
Alignment Healthcare, Inc.
NASDAQ:ALHC
$4.08B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
ICU Medical, Inc.
NASDAQ:ICUI
$3.55B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.01B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.95B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.58B
GRAIL, Inc.
NASDAQ:GRAL
$2.57B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.02B
What is the latest NVST filing?
The latest filing shown is 8-K dated Jun 3, 2026.
How many recent filings does NVST have?
Intrinsic Alpha currently shows 20 recent filings for NVST.
Explore More
Continue the stock analysis
Jump to another research area for this company.